Company Search:
Advanced Search
Sponsored Links
North China Pharmaceutical, Limited Company Snapshot
North China Pharmaceutical, Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares North China Pharmaceutical, Limited with three other companies in this sector in China: Shanghai Shyndec Pharmaceutical Co Ltd (2017 sales of 8.52 billion Chinese Renmimbi [US$1.26 billion] of which 60% was Drug Products), Dong-E-E-Jiao Co Ltd (7.37 billion Chinese Renmimbi [US$1.09 billion] of which 87% was Medicine Manufacturing), and WuXi AppTec Co Ltd (7.74 billion Chinese Renmimbi [US$1.14 billion] of which 53% was Experimental service in China).

Sales Analysis. During the year ended December of 2017, sales at North China Pharmaceutical, Limited were 7.71 billion Chinese Renmimbi (US$1.14 billion). This is a decrease of 4.6% versus 2016, when the company's sales were 8.08 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 51.9% decline in Medicine and Other Logistics Trade, from 2.20 billion Chinese Renmimbi to 1.06 billion Chinese Renmimbi. There were also decreases in sales in Medical Intermediate (down 30.4% to 118.75 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Chemical Preparation Medicine (up 10.4% to 3.82 billion Chinese Renmimbi) and Chemical Raw Medicine (up 6.2% to 1.77 billion Chinese Renmimbi) and Biopharmacy (up 113.2% to 652.00 million Chinese Renmimbi) and Other Main Operations (up 16.2% to 216.98 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
North China Pharmaceutical, Limited
  Stock Performance Chart for North China Pharmaceutical, Limited
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 4.22
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 1.4%  
4 Weeks -4.3%   52 Weeks -1.4%  
North China Pharmaceutical, Limited Key Data:
  Ticker: 600812 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 7,708,944,068
(Year Ending Jan 2018).
Employees: 10,636
  Currency: Chinese Renmimbi Market Cap: 6,881,995,956
  Fiscal Yr Ends: December Shares Outstanding: 1,630,804,729
  Share Type: A Gu Closely Held Shares: 914,862,975
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.